Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012–2018: Evidence from Claims Data of a Large Insurance
Objectives: Guidelines recommend colorectal cancer (CRC) screening by fecal occult blood test (FOBT) or colonoscopy. In 2013, Switzerland introduced reimbursement of CRC screening by mandatory health insurance for 50-69-years-olds, after they met their deductible. We hypothesized that the 2013 reimb...
Enregistré dans:
Auteurs principaux: | Rémi Schneider, Markus Näpflin, Lamprini Syrogiannouli, Sarah Bissig, Kali Tal, Jean-Luc Bulliard, Cyril Ducros, Oliver Senn, Kevin Selby, Caroline Bähler, Eva Blozik, Reto Auer |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5902c84a04d44948a4b6ea3d015bf56a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Test de sangre oculta en deposiciones para programas de cribado de cáncer colorrectal: actualización
par: Wielandt,Ana María, et autres
Publié: (2021) -
Anti-immigration Agenda of Populist Parties in Switzerland
par: E. P. Shavlay, et autres
Publié: (2021) -
A Review of the Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: Implications and Solutions
par: Suneha Sundaram, et autres
Publié: (2021) -
Recursos creativos en la ayuda humanitaria suiza hacia España y el sur de Francia (1937-1943) /
par: Schmöller, Natascha
Publié: (2019) -
Price trends of reimbursed oncological drugs in Switzerland in 2005-2019: A descriptive analysis.
par: Yael Rachamin, et autres
Publié: (2021)